News About: Goverment
Agreement in 3 way talks promptly to reflect in enforcement decrees.
According to the report of Minister Choi Sun-jung of MOHW presented to the President on Jan. 31 the MOHW plans to make revision of the enforcement decree of the pharmaceutical affairs law to reflect the agreed topics ...
Medical reform program unfavorable only to people and pharmacies.
The government's medical and pharmacy role separation system has been almost 6 months since it launched in Aug. last year after one month probation period. However, this reform program seems rather to go giving damage...
Clinical study institutes to inspect in February
The KFDA plans to inspect the KGCP (Korea Good Clinical Practice) institutes during coming February. The KFDA said that about 69 clinical study institutes should get the inspection, of which 43 already completed to pr...
Scope of bio-equivalent test exemtpion more defined.
The KFDA has refined the standards for the bio-equivalent test in order to enhance its credibility and announced it for legislation in conformance to the newly revised pharmaceutical affairs law.
The Article 23 (su...
Specialized administration system for bio-engineering products to build up.
The KFDA plans to establish the Bio-engineering Products Division, taking care of all bio-engineering products to meet the new knowledge industrial needs, and the Division will build up a special administrative system...
One year probation given to retail pharmacies already in unfair business collusion.
The Pharmaceutical Affairs Law Revision Subcommittee affiliated to the Health and Welfare Committee of the National Assembly finally decided all issues raised by the 3 way talks of the government, the medical and the ...
Quasi-drug price labelling system to postpone 6 more months.
The price labelling system applicable to all quasi-drugs as originally planned to implement from Jan. 1 this year has put off until coming June, considering a full probation period for manufacturers to consume all sto...
Business collusion between medical institutes and pharmacies to be rooted out.
While the revised bill of pharmaceutical affairs law is kept in deadlock mainly due to the crippled operation of the National Assembly, the MOHW has shown a definite position against the business collusion between med...
845 cases of unfair pharmacy practices under administrative measures.
To ensure the new medical reform programs for a soft landing, the government is seriously considering more illustrative cases of enactment or other preventive measures against any business collusion practices between ...
Cancer treatment for children to exclude from medical reform programs.
The Pharmaceutical Affairs Law Revision Subcommittee affiliated to the Health and Welfare Committee of the National Assembly intensively discussed the revised bill raised by the 3 way talks of the government, the medi...
